Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ongini

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive ratsE Ongini, S Milani, M Marzanatti, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive ratsC Casati, A Monopoli, A Forlani, et al.
British Journal of Pharmacology|February 29, 2000
A(2A) adenosine receptors in human peripheral blood cellsS Gessi, K Varani, S Merighi, et al.
Life Sciences|July 28, 1986
3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamineM L Porceddu, O Giorgi, E Ongini, et al.
European Journal of Pharmacology|May 20, 1985
SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphineG Mereu, M Collu, E Ongini, et al.
European Journal of Pharmacology|June 23, 1994
In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbitD Sandoli, P J Chiu, M Chintala, et al.
European Journal of Pharmacology|March 17, 1987
Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretionA C Rovescalli, N Brunello, A Monopoli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 1999
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptorsE Ongini, S Dionisotti, S Gessi, et al.
British Journal of Pharmacology|May 30, 1998
[3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranesK Varani, S Gessi, S Dionisotti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1993
Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissuesA Conti, A Monopoli, M Gamba, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1991
Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive ratsE Ongini, S Milani, M Marzanatti, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Telemetry monitoring of hemodynamic effects induced over time by adenosine agonists in spontaneously hypertensive ratsC Casati, A Monopoli, A Forlani, et al.
British Journal of Pharmacology|February 29, 2000
A(2A) adenosine receptors in human peripheral blood cellsS Gessi, K Varani, S Merighi, et al.
Life Sciences|July 28, 1986
3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamineM L Porceddu, O Giorgi, E Ongini, et al.
European Journal of Pharmacology|May 20, 1985
SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphineG Mereu, M Collu, E Ongini, et al.
European Journal of Pharmacology|June 23, 1994
In vivo and ex vivo effects of adenosine A1 and A2 receptor agonists on platelet aggregation in the rabbitD Sandoli, P J Chiu, M Chintala, et al.
European Journal of Pharmacology|March 17, 1987
Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretionA C Rovescalli, N Brunello, A Monopoli, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 5, 1999
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptorsE Ongini, S Dionisotti, S Gessi, et al.
British Journal of Pharmacology|May 30, 1998
[3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranesK Varani, S Gessi, S Dionisotti, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1993
Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissuesA Conti, A Monopoli, M Gamba, et al.
Pageof 14